Position in CRBU
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$120,684
+$14,238 QoQ
Shares Held
68,571
-41.2% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 137 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. CRBU ranks #267 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in CRBU
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,684 | 68,571 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $106,446 | 116,590 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $204,249 | 128,459 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $248,771 | 126,924 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $204,860 | 124,915 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $629,737 | 122,517 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $682,225 | 119,062 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $517,186 | 108,198 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $367,676 | 86,512 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $464,481 | 87,473 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $535,169 | 85,218 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $895,357 | 84,868 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $414,515 | 76,338 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $443,926 | 48,358 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $297,650 | 19,725 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $420,088 | 17,599 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||